Preconception expanded carrier screening: a focus group study with relatives of mucopolysaccharidosis type III patients and the general population

[1]  L. Haverman,et al.  Preconception expanded carrier screening: Impact of information presented by text or video on genetic knowledge and attitudes , 2020, Journal of genetic counseling.

[2]  N. Laing,et al.  Gene selection for the Australian Reproductive Genetic Carrier Screening Project (“Mackenzie’s Mission”) , 2020, European Journal of Human Genetics.

[3]  L. Haverman,et al.  Attitudes of relatives of mucopolysaccharidosis type III patients toward preconception expanded carrier screening , 2020, European Journal of Human Genetics.

[4]  H. Peeters,et al.  Interest in expanded carrier screening among individuals and couples in the general population: systematic review of the literature. , 2020, Human reproduction update.

[5]  C. Wright,et al.  Expanded universal carrier screening and its implementation within a publicly funded healthcare service , 2019, Journal of Community Genetics.

[6]  W. Grody,et al.  International perspectives on the implementation of reproductive carrier screening , 2019, Prenatal diagnosis.

[7]  S. Antonarakis.  Carrier screening for recessive disorders , 2019, Nature Reviews Genetics.

[8]  F. Boardman,et al.  Preventing lives affected by hemophilia: A mixed methods study of the views of adults with hemophilia and their families toward genetic screening , 2019, Molecular genetics & genomic medicine.

[9]  A. Ranchor,et al.  Expanded carrier screening for autosomal recessive conditions in health care: Arguments for a couple‐based approach and examination of couples' views , 2019, Prenatal diagnosis.

[10]  K. Abbott,et al.  Feasibility of couple-based expanded carrier screening offered by general practitioners , 2019, European Journal of Human Genetics.

[11]  K. Goddard,et al.  The evolving landscape of expanded carrier screening: challenges and opportunities , 2018, Genetics in Medicine.

[12]  P. Borry,et al.  A systematic analysis of online marketing materials used by providers of expanded carrier screening , 2018, Genetics in Medicine.

[13]  G. Ravenscroft,et al.  Measuring the impact of genetic knowledge on intentions and attitudes of the community towards expanded preconception carrier screening , 2018, Journal of Medical Genetics.

[14]  M. Cowley,et al.  Beyond the panel: preconception screening in consanguineous couples using the TruSight One “clinical exome” , 2018, Genetics in Medicine.

[15]  K. Goddard,et al.  Lessons Learned From A Study Of Genomics-Based Carrier Screening For Reproductive Decision Making. , 2018, Health affairs.

[16]  Suzanne M. O’Neill,et al.  Adopted Individuals’ Views on the Utility and Value of Expanded Carrier Screening , 2018, Journal of Genetic Counseling.

[17]  K. Goddard,et al.  Time Costs for Genetic Counseling in Preconception Carrier Screening with Genome Sequencing , 2018, Journal of Genetic Counseling.

[18]  K. Goddard,et al.  Patient perspectives on the use of categories of conditions for decision making about genomic carrier screening results , 2018, American journal of medical genetics. Part A.

[19]  F. Wijburg,et al.  Failure to shorten the diagnostic delay in two ultra-orphan diseases (mucopolysaccharidosis types I and III): potential causes and implications , 2018, Orphanet Journal of Rare Diseases.

[20]  P. Borry,et al.  Expanded carrier screening for monogenic disorders: where are we now? , 2018, Prenatal diagnosis.

[21]  H. Kayserili,et al.  Responsible implementation of expanded carrier screening , 2017, European Journal of Human Genetics.

[22]  F. Griffiths,et al.  The role of experiential knowledge within attitudes towards genetic carrier screening: A comparison of people with and without experience of spinal muscular atrophy , 2017, Health expectations : an international journal of public participation in health care and health policy.

[23]  S. Lindheim,et al.  Patients’ Awareness and Attitudes Towards Genetic Carrier Screening [22H] , 2017 .

[24]  H. Peeters,et al.  Expanded carrier screening in a reproductive context. Towards a responsible implementation in the healthcare system , 2017 .

[25]  Marian J. Gilmore,et al.  Reasons for Declining Preconception Expanded Carrier Screening Using Genome Sequencing , 2017, Journal of Genetic Counseling.

[26]  I. Huys,et al.  Public Views on Genetics and Genetic Testing: A Survey of the General Public in Belgium. , 2017, Genetic testing and molecular biomarkers.

[27]  E. M. Vos,et al.  Stakeholder perspectives on the implementation of genetic carrier screening in a changing landscape , 2017, BMC Health Services Research.

[28]  F. Boardman,et al.  Population screening for spinal muscular atrophy: A mixed methods study of the views of affected families , 2017, American journal of medical genetics. Part A.

[29]  S. Janssens,et al.  Designing expanded carrier screening panels: results of a qualitative study with European geneticists. , 2016, Personalized Medicine.

[30]  P. Larkin,et al.  Parents’ experiences of living with, and caring for children, adolescents and young adults with Mucopolysaccharidosis (MPS) , 2016, Orphanet Journal of Rare Diseases.

[31]  G. Wert,et al.  Advantages of expanded universal carrier screening: what is at stake? , 2016, European Journal of Human Genetics.

[32]  U. Kihlbom.  Ethical issues in preconception genetic carrier screening , 2016, Upsala journal of medical sciences.

[33]  R. Sinke,et al.  Population-based preconception carrier screening: how potential users from the general population view a test for 50 serious diseases , 2016, European Journal of Human Genetics.

[34]  H. Kayserili,et al.  Responsible implementation of expanded carrier screening , 2016, European Journal of Human Genetics.

[35]  M. Cornel,et al.  Changing to NIPT as a first‐tier screening test and future perspectives: opinions of health professionals , 2015, Prenatal diagnosis.

[36]  A. Paepe,et al.  Attitudes of cystic fibrosis patients and parents toward carrier screening and related reproductive issues , 2015, European Journal of Human Genetics.

[37]  Mary E Norton,et al.  Expanded carrier screening in reproductive medicine-points to consider: a joint statement of the American College of Medical Genetics and Genomics, American College of Obstetricians and Gynecologists, National Society of Genetic Counselors, Perinatal Quality Foundation, and Society for Maternal-Feta , 2015, Obstetrics and gynecology.

[38]  I. Haque,et al.  Systematic Classification of Disease Severity for Evaluation of Expanded Carrier Screening Panels , 2014, PloS one.

[39]  J. E. Wraith,et al.  Parental social support, coping strategies, resilience factors, stress, anxiety and depression levels in parents of children with MPS III (Sanfilippo syndrome) or children with intellectual disabilities (ID) , 2013, Journal of Inherited Metabolic Disease.

[40]  W. Dondorp,et al.  Arrays in postnatal and prenatal diagnosis: An exploration of the ethics of consent , 2012, Human Mutation.

[41]  C. Molster,et al.  Perceptions of population cystic fibrosis prenatal and preconception carrier screening among individuals with cystic fibrosis and their family members. , 2011, Genetic testing and molecular biomarkers.

[42]  S. Metcalfe,et al.  “It's something I need to consider”: Decisions about carrier screening for fragile X syndrome in a population of non‐pregnant women , 2009, American journal of medical genetics. Part A.

[43]  M. Aitken,et al.  ‘It is not in my world’: an exploration of attitudes and influences associated with cystic fibrosis carrier screening , 2008, European Journal of Human Genetics.

[44]  D. Skinner,et al.  Screening for Fragile X Syndrome: Parent attitudes and perspectives , 2003, Genetics in Medicine.

[45]  L. Henneman,et al.  Preconceptional couple screening for cystic fibrosis carrier status: couples prefer full disclosure of test results , 2002, Journal of medical genetics.

[46]  D. L. Doyle,et al.  Genetic Counseling and Screening of Consanguineous Couples and Their Offspring: Recommendations of the National Society of Genetic Counselors , 2002, Journal of Genetic Counseling.

[47]  E. Parens,et al.  Disability rights critique of prenatal genetic testing: reflections and recommendations. , 1999, Mental retardation and developmental disabilities research reviews.

[48]  L. Haverman,et al.  Attitudes of the general population towards preconception expanded carrier screening for autosomal recessive disorders including inborn errors of metabolism. , 2019, Molecular genetics and metabolism.

[49]  L. Haverman,et al.  Psychosocial Functioning in Parents of MPS III Patients. , 2019, JIMD reports.

[50]  G. Leung,et al.  Population screening. , 2003, The New England journal of medicine.

[51]  Lia Litosseliti,et al.  Using focus groups in research , 2003 .